151519-50-5,MFCD24386508
Catalog No.:AA00ADD6

151519-50-5 | Rapamycin, 7-O-demethyl-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
2.5mg
≥85%
2 weeks  
$1,188.00   $832.00
- +
5mg
≥85%
2 weeks  
$1,852.00   $1,296.00
- +
10mg
≥85%
2 weeks  
$3,078.00   $2,155.00
- +
25mg
≥85%
2 weeks  
$5,224.00   $3,657.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00ADD6
Chemical Name:
Rapamycin, 7-O-demethyl-
CAS Number:
151519-50-5
Molecular Formula:
C50H77NO13
Molecular Weight:
900.1453
MDL Number:
MFCD24386508
SMILES:
CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@H]([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H](CC[C@H]2C)C[C@H](O)/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C1)C)/C)O)OC)C)C)/C)C
Properties
Computed Properties
 
Complexity:
1740  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
15  
Defined Bond Stereocenter Count:
4  
Formal Charge:
0  
Heavy Atom Count:
64  
Hydrogen Bond Acceptor Count:
13  
Hydrogen Bond Donor Count:
4  
Isotope Atom Count:
0  
Rotatable Bond Count:
5  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
5.5  

Literature

Title: A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20100601

Title: EXCELLA First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20080501

Title: James Amigo Chan, et al. Process for producing rapamycin derivatives. WO1994012655A1.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:151519-50-5 Molecular Formula|151519-50-5 MDL|151519-50-5 SMILES|151519-50-5 Rapamycin, 7-O-demethyl-
Catalog No.: AA00ADD6
151519-50-5,MFCD24386508
151519-50-5 | Rapamycin, 7-O-demethyl-
Pack Size: 2.5mg
Purity: ≥85%
2 weeks
$1,188.00 $832.00
Pack Size: 5mg
Purity: ≥85%
2 weeks
$1,852.00 $1,296.00
Pack Size: 10mg
Purity: ≥85%
2 weeks
$3,078.00 $2,155.00
Pack Size: 25mg
Purity: ≥85%
2 weeks
$5,224.00 $3,657.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00ADD6
Chemical Name: Rapamycin, 7-O-demethyl-
CAS Number: 151519-50-5
Molecular Formula: C50H77NO13
Molecular Weight: 900.1453
MDL Number: MFCD24386508
SMILES: CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@H]([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H](CC[C@H]2C)C[C@H](O)/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C1)C)/C)O)OC)C)C)/C)C
Properties
Complexity: 1740  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 15  
Defined Bond Stereocenter Count: 4  
Formal Charge: 0  
Heavy Atom Count: 64  
Hydrogen Bond Acceptor Count: 13  
Hydrogen Bond Donor Count: 4  
Isotope Atom Count: 0  
Rotatable Bond Count: 5  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 5.5  
Literature fold

Title: A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology20100601

Title: EXCELLA First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology20080501

Title: James Amigo Chan, et al. Process for producing rapamycin derivatives. WO1994012655A1.

Building Blocks More >
174532-82-2
174532-82-2
3-Hydroxy Nevirapine
AA00ADKN | MFCD28899032
176168-78-8
176168-78-8
cis-Terbinafine Hydrochloride
AA00ADST | MFCD25974023
153012-65-8
153012-65-8
PF 2825
AA00AE0N | MFCD31562951
128350-67-4
128350-67-4
2-Cyclopentene-1-carboxylicacid,2-methyl-4-oxo-,methylester(9CI)
AA00AEPA | MFCD24695868
174846-84-5
174846-84-5
Zinc oxide
AA01X588 | MFCD00011300
186268-77-9
186268-77-9
Methyl (2s)-1-(3,3-dimethyl-2-oxopentanoyl)pyrrolidine-2-carboxylate
AA00AK8J | MFCD02179273
151486-56-5
151486-56-5
[[(4-Butyl-3,5-dimethyl-1h-pyrrol-2-yl)(4-butyl-3,5-dimethyl-2h-pyrrol-2-ylidene)methyl]methane](difluoroborane)
AA00AKKH | MFCD28386090
19139-74-3
19139-74-3
2,3:4,5-Di-o-isopropylidene-d-arabitol
AA00AL6M | MFCD00063387
189996-60-9
189996-60-9
Furo[3,4-d]-1,3-dioxol-4-ol, tetrahydro-2,2-dimethyl-, (3aR,6aR)-
AA00AM1K | MFCD15145031
17271-15-7
17271-15-7
3-Chloro-N-isopropylbenzamide
AA00AMKF | MFCD01214027
Submit
© 2017 AA BLOCKS, INC. All rights reserved.